124 related articles for article (PubMed ID: 2068474)
21. Safety of aztreonam in patients with cystic fibrosis and allergy to beta-lactam antibiotics.
Jensen T; Pedersen SS; Høiby N; Koch C
Rev Infect Dis; 1991; 13 Suppl 7():S594-7. PubMed ID: 2068465
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with aztreonam in Germany and Austria.
Stille W; Gillissen J
Rev Infect Dis; 1985; 7 Suppl 4():S825-30. PubMed ID: 3909342
[TBL] [Abstract][Full Text] [Related]
23. Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.
Ariza J; Xiol X; Esteve M; Fernández Bañeres F; Liñares J; Alonso T; Gudiol F
Hepatology; 1991 Jul; 14(1):91-8. PubMed ID: 2066075
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
Barriere SL
Clin Pharm; 1986 Jan; 5(1):24-33. PubMed ID: 3512153
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients.
Smith PF; Ballow CH; Booker BM; Forrest A; Schentag JJ
Clin Ther; 2001 Aug; 23(8):1231-44. PubMed ID: 11558860
[TBL] [Abstract][Full Text] [Related]
26. Role of aztreonam in lower respiratory tract infections.
Cook JL
Urology; 1988 Jun; 31(6 Suppl):33-6. PubMed ID: 3287748
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the immunologic cross-reactivity of aztreonam in patients with cystic fibrosis who are allergic to penicillin and/or cephalosporin antibiotics.
Moss RB; McClelland E; Williams RR; Hilman BC; Rubio T; Adkinson NF
Rev Infect Dis; 1991; 13 Suppl 7():S598-607. PubMed ID: 2068466
[TBL] [Abstract][Full Text] [Related]
28. Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients.
Knockaert DC; Dejaeger E; Nestor L; Verbist L; Pelemans W
Age Ageing; 1991 Mar; 20(2):135-9. PubMed ID: 2053504
[TBL] [Abstract][Full Text] [Related]
29. Prophylaxis of urinary tract infection in renal transplantation: comparison of three different protocols using ceftriaxone-cloxacillin, aztreonam-cloxacillin, or aztreonam-amoxycillin-clavulanic acid.
Castelao AM; Soto K; Grinyó JM; Gilvernet S; Serón D; Torras J; Riera L; Cruzado JM; Alsina J
Transplant Proc; 1995 Aug; 27(4):2277-9. PubMed ID: 7652804
[No Abstract] [Full Text] [Related]
30. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Rolston KV; Bodey GP; Elting L
Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
[TBL] [Abstract][Full Text] [Related]
31. Summary of worldwide clinical trials of aztreonam in patients with lower respiratory tract infections.
Swabb EA; Cone CO; Muir JG
Rev Infect Dis; 1985; 7 Suppl 4():S675-8. PubMed ID: 3909323
[TBL] [Abstract][Full Text] [Related]
32. Controlled trial of aztreonam vs. tobramycin and azlocillin for acute pulmonary exacerbations of cystic fibrosis.
Bosso JA; Black PG
Pediatr Infect Dis J; 1988 Mar; 7(3):171-6. PubMed ID: 3128767
[TBL] [Abstract][Full Text] [Related]
33. Gram-negative bacillary pneumonia in the nosocomial setting. Role of aztreonam therapy.
Cook JL
Am J Med; 1990 Mar; 88(3C):34S-37S; discussion 38S-42S. PubMed ID: 2316557
[TBL] [Abstract][Full Text] [Related]
34. Empiric antibiotic use--aztreonam as a model.
Levin S
Am J Med; 1990 Mar; 88(3C):21S-23S; discussion 38S-42S. PubMed ID: 2316555
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
Naber KG; Dette GA; Kees F; Knothe H; Grobecker H
J Antimicrob Chemother; 1986 Apr; 17(4):517-27. PubMed ID: 3710959
[TBL] [Abstract][Full Text] [Related]
36. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
37. The use of aztreonam in the cystic fibrosis patient.
Matsen JM; Bosso JA
Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S117-9; discussion S128-32. PubMed ID: 2682510
[TBL] [Abstract][Full Text] [Related]
38. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience with aztreonam for treatment of infections in children.
Stutman HR
Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of aztreonam in the treatment of skeletal infections due to Pseudomonas aeruginosa.
Conrad DA; Williams RR; Couchman TL; Lentnek AL
Rev Infect Dis; 1991; 13 Suppl 7():S634-9. PubMed ID: 2068473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
